Nytricx, Inc.
Athens, GA Doing business as Nytricx Inc.
- UEI
- GF9DV4ACBHH8
- CAGE
- 9DZ67
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 220 Riverbend Rd Rm 27, Athens, GA 30602, USA
- Website
- nytricx.com
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 59 Miscellaneous Retail
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About Nytricx, Inc.
Nytricx, Inc. is a corporate entity registered in SAM.gov, classified as a self-certified small disadvantaged business specializing in developing advanced medical technologies with a focus on nitric oxide (NO) release polymer technologies. The company concentrates on creating innovative medical devices and surface coatings that address critical challenges in medical interventions, particularly targeting infection prevention, thrombosis reduction, and improved biocompatibility in various medical applications.
In terms of federal contract awards, Nytricx, Inc. has secured a notable contract with the Department of Health and Human Services, specifically the Office of the Assistant Secretary for Preparedness and Response. The $745,973 firm-fixed-price contract involves research and development of an extracorporeal membrane oxygenation (ECMO) circuit with nitric oxide-releasing surface coatings designed to prevent thrombosis and infection. The contract, awarded on September 3, 2024, with a performance period ending March 9, 2026, was not set aside for any specific business type and represents the company's first prime federal contract award.
Regarding federal grant awards, Nytricx, Inc. has received multiple project grants from prestigious federal agencies, including the National Heart, Lung, and Blood Institute, Defense Health Agency, and National Institute of Diabetes and Digestive and Kidney Diseases. These grants focus on developing advanced medical technologies such as endovascular prosthetic graft devices, antimicrobial wound dressings, and specialized medical device coatings. Specific projects include creating ultra-slippery antibacterial surfaces for urological catheters, developing nitric oxide-releasing intravascular medical catheters to combat infection and thrombosis, and designing an endovascular prosthetic graft device to reduce complications like infection, neointimal proliferation, and thrombosis. The grant awards range from $311,824 to support specific research initiatives, with performance periods typically spanning one to two years.
Quick answers
What is Nytricx, Inc.'s UEI?
Nytricx, Inc.'s Unique Entity ID (UEI) in SAM.gov is GF9DV4ACBHH8.
What is Nytricx, Inc.'s CAGE code?
Nytricx, Inc.'s CAGE code is 9DZ67.
What is Nytricx, Inc.'s primary NAICS code?
Nytricx, Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Nytricx, Inc. located?
Nytricx, Inc.'s physical address in SAM.gov is 220 Riverbend Rd Rm 27, Athens, GA 30602, USA.
Is Nytricx, Inc. registered in SAM.gov?
Yes. Nytricx, Inc.'s SAM.gov registration is active through April 6, 2027.
What is Nytricx, Inc.'s most recent federal award?
Nytricx, Inc.'s most recent federal grant award is Engineering nitric oxide releasing intravascular catheters with solid slippery surfaces to combat infection and… (R43HL184590), from National Heart Lung and Blood Institute, on August 1, 2026.
On GovTribe
See Nytricx, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors